Medik8 Crystal Retinal 3 Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

MEDITHERAPY is the best-performing medik8 crystal retinal 3 brand in July 2026, moving 100,000 units across 1 ASIN for 21.3% of Top 10 volume. celimax follows with 100,000 units (21.3%), ahead of medicube on 60,000 units (12.8%).

Volume is spread across 8 brands, with the top three holding 55.3% between them. No single label controls the shelf, which usually leaves room for a well-differentiated listing to take share without outspending an incumbent. Average selling prices among the leaders run from $15.12 to $17.49, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. On the growth side, B0GZ19T1SM leads positive momentum with ▲ 66.7% MoM growth on 10K units, with B0GCC2JV65 close behind at ▲ 33.3% MoM on 40K units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.